SLC37A4 and obesity disorder: Indeed, chlorogenic acid has anti-diabetic and anti-obesity properties by reducing glucose absorption in the small intestine through inhibition of the enzyme glucose-6-phosphate translocase, inhibiting the hepatic enzyme glucose-6-phosphatase, and increasing phosphorylation of AMP-activated protein kinase [46,47].